Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schmauss

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Psychiatrische Praxis|December 1, 2004
[Prevalence of mental disorders in the out-patient clinic for environmental diseases (Umweltmedizinische Ambulanz) in Augsburg central hospital]Lydia Teufel-Maier, Monika Schulze, Max Schmauss, et al.
International Clinical Psychopharmacology|February 13, 2007
Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidoneMax Schmauss, Emilio Sacchetti, Jean-Pierre Kahn, et al.
Psychiatrische Praxis|September 18, 2003
[Comparative Efficacy of Flupentixol and Risperidone on Schizophrenic Negative Symptoms]Michael Philipp, Otto M. Lesch, Max Schmauss, et al.
Psychiatrische Praxis|September 26, 2003
[Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia]Michael Philipp, Otto M Lesch, Max Schmauss, et al.
BMJ Open|December 26, 2019
Long-term outcomes in patients with severe depression after in-hospital treatment - study protocol of the depression long-term Augsburg (DELTA) studyInge Kirchberger, Barbara Maleckar, Christine Meisinger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2007
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptomsStephan Ruhrmann, Werner Kissling, Otto-Michael Lesch, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 12, 2010
Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance StudyThomas Messer, Max Schmauss, Terez Spevakne-Goeroecs, et al.
Der Nervenarzt|February 26, 2024
[Erratum to: Support for families with a mentally ill parent : Which forms of help do mentally ill parents utilize and which would they like to have?]Stefanie Bienioschek, Daria Nolkemper, Jennifer Schroth, et al.
Der Nervenarzt|December 18, 2023
[Support for families with a mentally ill parent : Which forms of help do mentally ill parents utilize and which would they like to have?]Stefanie Bienioschek, Daria Nolkemper, Jennifer Schroth, et al.
Der Nervenarzt|June 4, 2002
[Critical comment on "Professional help for implementing the consensus regarding psychiatric institute ambulatory care of the MDK Competence Center for Psychiatry and Psychotherapy (April 2001)]Joachim Hübner, Horst Lorenzen, Andreas Spengler, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Psychiatrische Praxis|December 1, 2004
[Prevalence of mental disorders in the out-patient clinic for environmental diseases (Umweltmedizinische Ambulanz) in Augsburg central hospital]Lydia Teufel-Maier, Monika Schulze, Max Schmauss, et al.
International Clinical Psychopharmacology|February 13, 2007
Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidoneMax Schmauss, Emilio Sacchetti, Jean-Pierre Kahn, et al.
Psychiatrische Praxis|September 18, 2003
[Comparative Efficacy of Flupentixol and Risperidone on Schizophrenic Negative Symptoms]Michael Philipp, Otto M. Lesch, Max Schmauss, et al.
Psychiatrische Praxis|September 26, 2003
[Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia]Michael Philipp, Otto M Lesch, Max Schmauss, et al.
BMJ Open|December 26, 2019
Long-term outcomes in patients with severe depression after in-hospital treatment - study protocol of the depression long-term Augsburg (DELTA) studyInge Kirchberger, Barbara Maleckar, Christine Meisinger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2007
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptomsStephan Ruhrmann, Werner Kissling, Otto-Michael Lesch, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 12, 2010
Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance StudyThomas Messer, Max Schmauss, Terez Spevakne-Goeroecs, et al.
Der Nervenarzt|February 26, 2024
[Erratum to: Support for families with a mentally ill parent : Which forms of help do mentally ill parents utilize and which would they like to have?]Stefanie Bienioschek, Daria Nolkemper, Jennifer Schroth, et al.
Der Nervenarzt|December 18, 2023
[Support for families with a mentally ill parent : Which forms of help do mentally ill parents utilize and which would they like to have?]Stefanie Bienioschek, Daria Nolkemper, Jennifer Schroth, et al.
Der Nervenarzt|June 4, 2002
[Critical comment on "Professional help for implementing the consensus regarding psychiatric institute ambulatory care of the MDK Competence Center for Psychiatry and Psychotherapy (April 2001)]Joachim Hübner, Horst Lorenzen, Andreas Spengler, et al.
Pageof 5